Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Two votes cast to start BoE tapering

Thu, 23rd Sep 2021 12:08

(Alliance News) - Stock prices in London were slightly higher, even as both the US and UK central banks edged toward tapering economic stimulus.

The Monetary Policy Committee of the Bank of England voted by a majority of 7-2 to maintain quantitative easing at the current pace of GBP895 billion. Dave Ramsden and Michael Saunders cast dissenting votes to cut gilt QE to GBP840 billion. All 9 MPC members voted to keep interest rates unchanged, with the Bank Rate at 0.10%.

The pound was quoted at USD1.3674 on Thursday after the midday decision by the BoE, up from USD1.3659 at the London equities close Wednesday.

The FTSE 100 index was up 8.36 points, or 0.1%, at 7,091.71. The mid-cap FTSE 250 index was up 53.25 points, 0.2%, at 23,837.79. The AIM All-Share index was up 6.03 points, 0.5%, at 1,274.16.

The Cboe UK 100 index was up 0.2% at 705.40. The Cboe 250 was flat at 21,622.30. The Cboe Small Companies was 0.1% lower at 15,528.00.

In mainland Europe, the CAC 40 stock index in Paris and the DAX 40 index in Frankfurt were both up 0.8%.

Analysts at ActivTrades said investors welcomed Wednesday's policy statement from the US Fed. "[Chair] Jerome Powell confirmed tapering is on its way and will start sooner than expected. The Fed added it wouldn't need 'a very strong jobs report to go ahead with taper', which can be seen as a message to the market that the party will finally come to an end, mentioning November as a potentially good moment to scale back asset purchases.

"However, the market hasn't bought the rumour of any potential tapering to come but instead preferred to stick to the reality of the current extremely dovish environment that will remain for some time at least."

In the FTSE 100, Rolls-Royce was the best performer, up 3.4% at 126.26 pence after Berenberg raised its price target on the stock to 160p from 150p and reiterated its Buy rating.

Reckitt Benckiser was up 0.3%. The hygiene and home cleaning products firm said trading since its half-year results in July has been in line with management expectations.

Reckitt said it continued to be confident in delivering 2021 like-for-like net revenue growth in a range of 0% to 0.2% and an adjusted operating profit margin between 22.7% to 23.2%. Reckitt posted like-for-like net revenue growth of 12% and an adjusted operating profit margin of 23.6% for 2020.

Royal Mail shares were flat after the UK postal operator lifted its profit guidance and expressing confidence in its outlook.

In the five months to the end of August, total revenue grew by 8.2% year-on-year and by 18% compared to the same period in 2019.

In the domestic Royal Mail arm, revenue increased by 7.2% year-on-year and by 12% against the same period in 2019. The company said domestic parcel volumes are up by around third compared to pre-Covid levels and that it is maintaining its share of the UK market.

At its GLS international logistics unit, revenue rose 9.3% from the same time last year and by 31% versus the same period in 2019.

Looking ahead, Royal Mail expects adjusted operating profit for the six months to the end of September to be around GBP395 million to GBP400 million, with at least GBP230 million from the Royal Mail unit. This compares to profit of just GBP37 million a year ago, and would even exceed the GBP165 million posted for the same period in 2019.

At the other end of the large-caps, Entain was the worst performer, down 2.8%. The gambling firm was giving back some of its strong recent gains after it received a takeover approach from US peer DraftKings. The stock is up 22% this week alone.

Hargreaves Lansdown was down 2.0%, after the wealth manager's shares went ex-dividend, meaning new buyers no longer qualify for the latest payout.

GlaxoSmithKline was down 0.1% after Bloomberg reported on Wednesday that activist investor Bluebell Capital Partners has bought a stake in GlaxoSmithKline and criticised Chief Executive Officer Emma Walmsley.

In a letter seen by the news outlet, Bluebell called for a "thorough and robust process to identify the best (internal or external) candidate" to lead the company after it spins off its consumer division to focus on pharmaceuticals.

"The lack of Walmsley's industry knowledge was also very evident during the latest investor update," the letter said, echoing criticism from Elliott Investment Management.

Meanwhile, Marley Group confirmed its plans to list on London's Main Market, after saying earlier this month it was considering an initial public offering.

The Burton Upon Trent-based pitched roofing business did not disclose the number of shares to be issued, offer price or expected market capitalisation, but said it hopes to raise gross proceeds around GBP75 million. The IPO is likely to take place in October.

On the economic front, the UK private sector lost momentum in September with the rate of expansion in both output and new orders the weakest in seven months.

The IHS Markit-CIPS flash UK composite purchasing managers' index print was 54.1 points in September, below August's reading of 54.8.

The UK services PMI score was 54.6 points in September, down slightly from 55.0 in August and missed the market forecast, cited by FXStreet, of 55.0.

The UK manufacturing PMI reading was 56.3 points in September, sharply lower from 60.3 in August and missed the market estimate of 59.0.

All three UK PMI prints were the lowest seen in seven months.

"September's flash PMIs suggest that the economy is losing momentum a little faster than we originally anticipated, posing a downside risk to our view that the economy will return to its pre-pandemic level by November," commented analysts at Capital Economics.

The euro was priced at USD1.1715, down from USD1.1738.

A survey of eurozone business activity pointed to slower growth in September, Markit said, as bottlenecks curb activity and the input price gauge hit 21-year high. The flash headline composite purchasing managers' index fell sharply in September to 56.1 points from 59.0 points in August.

Any score above 50 represents growth, but the latest increase in business activity was the weakest since April, albeit still well above the survey's pre-pandemic long-run trend.

The flash services activity index read 56.3 points in September versus 59.0 points in August. The flash manufacturing output index fell back to 55.6 points in September from 59.0 points in August.

Against the Japanese yen, the dollar was trading at JPY109.87, up from JPY109.57.

Brent was quoted at USD75.94 a barrel Thursday at midday, higher against USD75.44 a barrel late Wednesday. Gold stood at USD1,771.22 an ounce, down from USD1,778.80.

US stock market futures were pointed to a higher open after the US Federal Reserve said the tapering of economic stimulus may "soon be warranted" as the economy edges closer to its employment and price stability goals.

The Dow Jones Industrial Average was called up 0.5%, the S&P 500 up 0.4%, and the Nasdaq Composite up 0.5%.

The Fed left its benchmark rate unchanged in the range of 0.00% to 0.25%. Chair Jerome Powell said the US economy has made progress towards the Fed's goals, and if things continue to advance at a speed that the Federal Reserve Open Market committee expects, a "moderation in the pace of asset purchases" may occur.

The Fed is currently buying at least USD80 billion in Treasury securities and USD40 billion in agency mortgage‑backed securities every month as part of its stimulus efforts.

Powell said that if the US economy continues to improve, "a gradual tapering process that concludes around the middle of next year is likely to be appropriate".

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more
11 Oct 2023 07:47

LONDON BRIEFING: Stocks lower; GSK settles Zantac case in California

(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.

Read more
9 Oct 2023 08:16

TOP NEWS: GSK inks agreement with Zhifei to promote shingles vaccine

(Alliance News) - GSK PLC on Monday said it has reached an exclusive agreement with Chongqing Zhifei Biological Products Ltd to co-promote its shingles vaccine, Shingrix, in China.

Read more
9 Oct 2023 07:42

LONDON BRIEFING: Metro Bank secures deal to shore up finances

(Alliance News) - Stocks in London are set to open higher on Monday as interest rate expectations held steady despite Friday's bumper US nonfarm payrolls report.

Read more
9 Oct 2023 07:20

GSK inks deal to promote shingles vaccine in China

(Sharecast News) - GSK has entered into a new exclusive vaccine partnership in China that will extend the availability of its shingle vaccine Shingrix, which will see the UK-listed group generate £2.5bn over the next three years.

Read more
8 Oct 2023 11:36

Sunday newspaper round-up: Renewi, Metro Bank, New homes

(Sharecast News) - Some of Renewi's major shareholders are divided as to whether the recycling company should engage with Australian suitor Macquarie. One major shareholder has told Renewi's board that it should not until Macquarie raised its £636m bid, but another top ten shareholder told The Sunday Times that it should talk to the Australian outfit anyways. Macquarie has until 26 October to make a firm offer. - The Sunday Times

Read more
6 Oct 2023 08:17

GSK raises £885.6m from Haleon share sale

(Sharecast News) - GSK said on Friday that it has sold 270m shares in Haleon - the consumer health business it spun off last year - raising around £885.6m.

Read more
6 Oct 2023 07:57

UPDATE: GSK banks GBP886 million from Haleon share sale

(Alliance News) - GSK PLC on Friday said it received GBP885.6 million in gross proceeds from its sale of shares in consumer healthcare spin-off Haleon PLC.

Read more
6 Oct 2023 07:46

LONDON BRIEFING: Wetherspoon swings to profit; UK house prices fall

(Alliance News) - Stocks in London are called to open higher on Friday, as investors eye a key nonfarm payroll reading in the US.

Read more
5 Oct 2023 15:47

UK dividends calendar - next 7 days

Friday 6 October 
Admiral Group PLCdividend payment date
Alfa Financial Software Holdings PLCspecial dividend payment date
Anglo-Eastern Plantations PLCdividend payment date
Blackrock World Mining Trust PLCdividend payment date
Cairn Homes PLCdividend payment date
Dalata Hotel Group PLCdividend payment date
Drax Group PLCdividend payment date
Glanbia PLCdividend payment date
GlobalData PLCdividend payment date
Goodwin PLCdividend payment date
Greggs PLCdividend payment date
Intertek Group PLCdividend payment date
Irish Continental Group PLCdividend payment date
JPMorgan American Investment Trust PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Land Securities Group PLCdividend payment date
Personal Assets Trust PLCdividend payment date
Quartix Technologies PLCdividend payment date
Serco Group PLCdividend payment date
Walker Crips Group PLCdividend payment date
Warehouse REIT PLCdividend payment date
Zotefoams PLCdividend payment date
Monday 9 October 
Henderson Smaller Cos Investment Trust PLCdividend payment date
LondonMetric Property PLCdividend payment date
Tuesday 10 October 
LSL Property Services PLCdividend payment date
Wednesday 11 October 
Assura PLCdividend payment date
Rathbones Group PLCdividend payment date
Thursday 12 October 
Blackrock Latin American Investment Trust PLCex-dividend payment date
Breedon Group PLCex-dividend payment date
Diageo PLCdividend payment date
GSK PLCdividend payment date
Howden Joinery Group PLCex-dividend payment date
i3 Energy PLCex-dividend payment date
Invesco Bond Income Plus Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
JPMorgan Mid Cap Investment Trust PLCex-dividend payment date
Kingfisher PLCex-dividend payment date
MP Evans Group PLCex-dividend payment date
Macfarlane Group PLCdividend payment date
North American Income Trust PLCex-dividend payment date
Oxford Instruments PLCdividend payment date
Persimmon PLCex-dividend payment date
Personal Group Holdings PLCex-dividend payment date
Primary Health Properties PLCex-dividend payment date
Ruffer Investment Co Ltdex-dividend payment date
Senior PLCex-dividend payment date
Spirax-Sarco Engineering PLCex-dividend payment date
Strategic Equity Capital PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
Taylor Wimpey PLCex-dividend payment date
Tesco PLCex-dividend payment date
TT Electronics PLCdividend payment date
WPP PLCex-dividend payment date
XP Power Ltddividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
3 Oct 2023 18:19

IN BRIEF: GSK's Jemperli approved in UK for endometrial cancer

GSK PLC - London-based pharmaceutical company - On Monday, announces that the UK Medicines & Health Products Regulatory Agency has authorised a new indication for Jemperli, also known as dostarlimab. The drug is used as a treatment for some types of endometrial cancer and an be used to treat patients that have a tumour abnormality called mismatch repair deficient/microsatellite instability-high when the cancer is at an advanced stage when first diagnosed or has returned after previous treatment. It is now authorised to be used together with chemotherapy to slow the progression of these cancers. GSK says it is the first medicine licensed as first line treatment for primary advanced or recurrent endometrial cancer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.